Envoy Medical
COCH
24 hedge funds and large institutions have $41.3M invested in Envoy Medical in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 76 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
74% less funds holding
Funds holding: 94 → 24 (-70)
77.5% less ownership
Funds ownership: 87.18% → 9.67% (-78%)
89% less capital invested
Capital invested by funds: $372M → $41.3M (-$331M)
91% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 76
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Sandia Investment Management
Boston,
Massachusetts
|
+$4.4M |
| 2 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$4.06M |
| 3 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$1.59M |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$1.45M |
| 5 |
CM
Crestline Management
Fort Worth,
Texas
|
+$1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$27.7M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$21M |
| 3 |
Millennium Management
New York
|
-$19.4M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$19.2M |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$15.3M |
COCH Hedge Fund Activity: Q1 2023 in Review
24 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q1 2023, worth a combined $41.3M — down 89% from $372M a quarter earlier.
Sellers outnumbered buyers: 76 funds closed out of COCH and 7 opened new positions — a net loss of 69 holders — while 7 trimmed existing stakes and 8 added.
The largest buyer was Sandia Investment Management, adding an estimated $4.4M. The largest seller was Aristeia Capital, exiting entirely with an estimated $27.7M sold.
- 24 institutional investors held Envoy Medical (COCH) as of Q1 2023, down from 94 in Q4 2022.
- Funds reported $41.3M of Envoy Medical stock for Q1 2023, down 89% quarter-over-quarter.
- 7 funds opened new Envoy Medical positions in Q1 2023 and 76 closed out, a net change of -69 holders.
- The largest Envoy Medical buyer in Q1 2023 was Sandia Investment Management, an estimated $4.4M added.
- The largest Envoy Medical seller in Q1 2023 was Aristeia Capital, an estimated $27.7M sold.
Based on aggregated 13F filings for Q1 2023.